Fidelity Investments’s Eton Pharmaceutcials ETON Stock Holding History

Fidelity Investments’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.5K	Sell	1,519 -1,557	-51%	-$27.2K	﹤0.01%	4250
2025 Q4	$52K	Sell	3,076 -2,618	-46%	-$46.1K	﹤0.01%	4093
2025 Q3	$124K	Buy	5,694 +5,239	+1,151%	+$86.9K	﹤0.01%	3576
2025 Q2	$6.48K	Buy	455 +445	+4,450%	+$7.04K	﹤0.01%	4647
2025 Q1	$130	Buy	+10	New	+$151	﹤0.01%	5111
2023 Q1	–	Sell	-900	Closed	-$2.52K	–	5357
2022 Q4	$2.52K	Buy	+900	New	+$2.42K	﹤0.01%	4452

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Fidelity Investments's ETON Position: Q1 2026 in Review

Fidelity Investments reduced its Eton Pharmaceutcials (ETON) stake by 51% in Q1 2026, selling an estimated $27.2K and leaving 1,519 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4250.

Fidelity Investments first reported a position in ETON in Q4 2022 and has held it in 6 quarters since. The position peaked at $124K in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

Fidelity Investments held 1,519 shares of Eton Pharmaceutcials worth $37.5K as of Q1 2026.
Fidelity Investments sold 1,557 Eton Pharmaceutcials shares in Q1 2026, an estimated $27.2K.
Eton Pharmaceutcials made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4250 holding.
Fidelity Investments first reported a position in Eton Pharmaceutcials in Q4 2022 and has held it in 6 quarters since.
Fidelity Investments's Eton Pharmaceutcials position peaked at $124K in Q3 2025.
116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.